Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARa Agonists as Leads for Retinal Disorders.
Blepharophimosis
Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Azacitidine Maintenance Therapy Post-Allogeneic Stem Cell Transplantation in Poor-Risk Acute Myeloid Leukemia.
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest. 2013 Jun; 123(6):2447-63.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Animals
Antibodies, Monoclonal, Murine-Derived
Brain Neoplasms
Cell Line, Tumor
Combined Modality Therapy
CTLA-4 Antigen
Female
Humans
Immunologic Factors
Immunomodulation
Immunotherapy
Injections, Intralesional
Lymphocyte Depletion
Lymphoma
Meningeal Neoplasms
Mice
Mice, Inbred BALB C
Mice, Nude
Mice, SCID
Neoplasm Transplantation
Oligodeoxyribonucleotides
Receptors, OX40
T-Lymphocytes, Regulatory
Toll-Like Receptor 9
Tumor Burden
authors with profiles
Robert Axtell